Novel etiopathophysiological aspects of thyrotoxic periodic paralysis

Nature Reviews Endocrinology

Volumn 7, Issue 11, 2011, Pages 657-667

  MacIel, Rui M B ^a   Lindsey, Susan C S ^a   Dias Da Silva, Magnus R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTITHYROID AGENT; DICLOFENAMIDE; ION CHANNEL; POTASSIUM; PROPRANOLOL; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THYROID HORMONE; THYROTROPIN;

ADJUVANT THERAPY; ASIAN; CARBOHYDRATE INTAKE; CHANNELOPATHY; DEPOLARIZATION; DISEASE DURATION; ENVIRONMENTAL FACTOR; ETHNICITY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HISPANIC; HOMEOSTASIS; HUMAN; HYPERTHYROIDISM; HYPOKALEMIA; INSULIN SENSITIVITY; MUSCLE EXCITATION; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PERIODIC PARALYSIS; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SKELETAL MUSCLE; THYROTOXIC PERIODIC PARALYSIS; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL;

ANIMALS; HUMANS; HYPOKALEMIA; HYPOKALEMIC PERIODIC PARALYSIS; THYROTOXICOSIS;

EID: 80054987440     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2011.58     Document Type: Review

References (120)

1. Silva, M. R., Chiamolera, M. I., Kasamatsu, T. S., Cerutti, J. M. & Maciel, R. M. Thyrotoxic hypokalemic periodic paralysis, an endocrine emergency: clinical and genetic features in 25 patients [Portuguese]. Arq. Bras. Endocrinol. Metabol. 48, 196-215 (2004).
2. Lin, S. H. Thyrotoxic periodic paralysis. Mayo Clin. Proc. 80, 99-105 (2005).
3. Dias da Silva, M. R. et al. Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha1 subunit gene (Cav1.1) are not associated with thyrotoxic hypokalaemic periodic paralysis. Clin. Endocrinol. (Oxf.) 56, 367-375 (2002). (Pubitemid 34310015)
4. Hackshaw, K. V. & Coker, E. Hypokalemic periodic paralysis in a hyperthyroid black woman. J. Natl Med. Assoc. 80, 1343-1344 (1988). (Pubitemid 19204402)
5. Kelley, D. E., Gharib, H., Kennedy, F. P., Duda, R. J. Jr & McManis, P. G. Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. Arch. Intern. Med. 149, 2597-2600 (1989). (Pubitemid 19283220)
6. Hay, I. D. & McDougall, I. R. Letter: Thyrotoxic periodic paralysis in Britain. Br. Med. J. 4, 761 (1975).
7. Engel, A. G. Thyroid function and periodic paralysis. Am. J. Med. 30, 327-333 (1961).
8. Rosenfeld, M. Acute aufsteigende lahmung bei morbus Basedow [German]. Klin. Wochenschr. (Berl.) 39, 538-540 (1902).
9. Dunlap, H. F. & Kepler, E. J. A syndrome resembling familial periodic paralysis occurring in the course of exolphthalmic goiter. Endocrinology 15, 541-546 (1931).
10. Pereira, V. G., Wajchenberg, B. L. & Quintão, E. R. Periodic paralysis associated with hyperthyroidism. Study of the precipitating factors. Arq. Bras. Endocrinol. Metabol. 17, 55-67 (1968).
11. Sterian, L. & Maciel, R. M. B. Paralisia periódica tirotóxica, relato de um caso e comentários etiopatogênicos [Portuguese]. Arq. Bras. Endocrinol. Metabol. 27, 161-162 (1983).
12. Ober, K. P. Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine (Baltimore) 71, 109-120 (1992).
13. Manoukian, M. A., Foote, J. A. & Crapo, L. M. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch. Intern. Med. 159, 601-606 (1999). (Pubitemid 29133885)
14. Dias da Silva, M. R., Cerutti, J. M., Arnaldi, L. A. & Maciel, R. M. A mutation in the KCNEvpotassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis. J. Clin. Endocrinol. Metab. 87, 4881-4884 (2002). (Pubitemid 35316320)
15. Ryan, D. P. et al. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell 140, 88-98 (2010).
16. Chen, L. et al. Clinical and molecular analysis of Chinese patients with thyrotoxic periodic paralysis. Eur. Neurol. 49, 227-230 (2003). (Pubitemid 36566240)
17. Ko, G. T. et al. Thyrotoxic periodic paralysis in a Chinese population. QJM 89, 463-468 (1996). (Pubitemid 26184332)
18. Zhang, M. Y. Clinical analysis of 50 cases of thyrotoxic periodic paralysis [Chinese]. Zhonghua Shen Jing Jing Shen Ke Za Zhi 20, 33-36 (1987).
19. Tamai, H. et al. HLA and thyrotoxic periodic paralysis in Japanese patients. J. Clin. Endocrinol. Metab. 64, 1075-1078 (1987). (Pubitemid 17067447)
20. Okihiro, M. M. & Beddow, R. M. Thyrotoxic periodic paralysis in Hawaii. Its predilection for the Japanese race. Neurology 15, 253-255 (1965).
21. Shiang, J. C. et al. Therapeutic analysis in Chinese patients with thyrotoxic periodic paralysis over 6 years. Eur. J. Endocrinol. 161, 911-916 (2009).
22. Maciel, R. M. B. Screening for thyrotoxic paralysis out of Asia: are we underestimating its frequency in the West? Presented at the 12th International Thyroid Congress, Kyoto, Japan. Endocr. J. 47 (Suppl. 2) WS-v(2000).
23. Magsino, C. H. Jr & Ryan, A. J. Jr. Thyrotoxic periodic paralysis. South. Med. J. 93, 996-100v(2000).
24. Bernard, J. D., Larson, M. A. & Norris, F. H. Jr. Thyrotoxic periodic paralysis in Californians of Mexican and Filipino ancestry. Calif. Med. 116, 70-74 (1972).
25. Castro Vilanova, M. D., Berbel, A., Posada, I. J. & Bermejo, F. Periodic thyrotoxic paralysis in Hispanics [Spanish]. Neurologia 12, 428-429 (1997).
26. Cesur, M. et al. Thyrotoxic hypokalaemic periodic paralysis in a Turkish population: three new case reports and analysis of the case series. Clin. Endocrinol. (Oxf.) 68, 143-152 (2008). (Pubitemid 350243494)
27. Chatterjee, A. K., Dhakam, Z., Morrish, N. J. & Manford, M. R. Thyrotoxic periodic paralysis in a Caucasian male. Hosp. Med. 65, 182-183 (2004). (Pubitemid 38938653)
28. Elston, M. S., Orr-Walker, B. J., Dissanayake, A. M. & Conaglen, J. V. Thyrotoxic, hypokalaemic periodic paralysis: Polynesians, an ethnic group at risk. Intern. Med. J. 37, 303-307 (2007). (Pubitemid 46744084)
29. Gordon, D. L., Agrawal, L., Swade, T. F. & Lawrence, A. M. Thyrotoxic hypokalemic periodic paralysis: six cases in non-Asian patients. Endocr. Pract. 4, 142-145 (1998).
30. Kilpatrick, R. E., Seiler-Smith, S. & Levine, S. N. Thyrotoxic hypokalemic periodic paralysis: report of four cases in black American males. Thyroid 4, 441-445 (1994).
31. Pichon, B. et al. Thyrotoxic periodic paralysis in Caucasian patients: a diagnostic challenge. Eur. J. Intern. Med. 16, 372-374 (2005). (Pubitemid 41755040)
32. Piraino Neuenschwander, P., Pumarino Carte, H., Bidegain González, F., Zura Jiménez, M. L. & Ferreiro Merino, F. Thyrotoxic hypokalemic periodic paralysis: 18 cases with different forms of thyrotoxicosis [Spanish]. Rev. Clin. Esp. 195, 294-297 (1995).
33. Reisin, R. C. et al. Thyrotoxic periodic paralysis in caucasians. Report of 8 cases. Neurologia 15, 222-225 (2000).
34. Sinharay, R. Hypokalaemic thyrotoxic periodic paralysis in the UK. QJM 96, 611-613 (2003).
35. Wild, E. Thyrotoxic periodic paralysis in a Maori patient. N. Z. Med. J. 117, U1204 (2004).
36. Williams, R. Thyrotoxic periodic paralysis in Navajos- HLA typing. West. J. Med. 142, 260-261 (1985). (Pubitemid 15135062)
37. Tran, H. A. et al. Thyrotoxic, hypokalaemic periodic paralysis in Australasian men. Intern. Med. J. 33, 91-94 (2003). (Pubitemid 36363642)
38. McFadzean, A. J. & Yeung, R. Familial occurrence of thyrotoxic periodic paralysis. Br. Med. J. 1, 760 (1969).
39. Shizume, K. et al. Comparison of the incidence of association of periodic paralysis and hyperthyroidism in Japan in 1957 and 1991. Endocrinol. Jpn. 39, 315-318 (1992).
40. McKenzie, T. Hypokalemic periodic paralysis of thyrotoxic origin: a case complicated by cultural differences. Can. Med. Assoc. J. 128, 950-951 (1983). (Pubitemid 13088715)
41. Nellen, H. et al. Thyrotoxic periodic paralysis in Mexican mestizo patients: a clinical, biochemical and HLA-serological study. Arch. Med. Res. 30, 74-76 (1999). (Pubitemid 29099519)
42. Iheonunekwu, N. C., Ibrahim, T. M., Davies, D. & Pickering, K. Thyrotoxic hypokalaemic paralysis in a pregnant Afro-Caribbean woman. A case report and review of the literature. West Indian Med. J. 53, 47-49 (2004). (Pubitemid 38477430)
43. Donovan, L., Parkins, V. M. & Mahalingham, A. Thyrotoxic periodic paralysis in pregnancy with impaired glucose tolerance: a case report and discussion of management issues. Thyroid 17, 579-583 (2007). (Pubitemid 47068122)
44. Richey, S. D. & Wendel, G. D. Jr. Thyrotoxic hypokalemic periodic paralysis following second-trimester prostaglandin-induced abortion. Obstet. Gynecol. 82 (Suppl.), 696-698 (1993). (Pubitemid 23276508)
45. Ptácek, L. J. Channel surfing. J. Clin. Endocrinol. Metab. 87, 4879-4880 (2002).
46. Leung, A. K. Familial 'hashitoxic' periodic paralysis. J. R. Soc. Med. 78, 638-640 (1985).
47. Hsieh, M. J. et al. Hypokalemic thyrotoxic periodic paralysis: clinical characteristics and predictors of recurrent paralytic attacks. Eur. J. Neurol. 15, 559-564 (2008).
48. Wong, G. W., Leung, T. F., Lo, A. F., Ahuja, A. T. & Cheng, P. S. Thyrotoxic periodic paralysis in a 14 year old boy. Eur. J. Pediatr. 159, 934 (2000).
49. Tagami, T., Usui, T., Shimatsu, A. & Naruse, M. Toxic thyroid adenoma presenting as hypokalemic periodic paralysis. Endocr. J. 54, 797-80v(2007).
50. Ober, K. P. & Hennessy, J. F. Jodbasedow and thyrotoxic periodic paralysis. Arch. Intern. Med. 141, 1225-1227 (1981). (Pubitemid 11017511)
51. Laroia, S. T., Zaw, K. M., Ganti, A. K., Newman, W. & Akinwande, A. O. Amiodarone-induced thyrotoxicosis presenting as hypokalemic periodic paralysis. South. Med. J. 95, 1326-1328 (2002). (Pubitemid 36109345)
52. Kiso, Y. et al. A case of thyrotropin (TSH)-secreting tumor complicated by periodic paralysis. Jpn. J. Med. 29, 399-404 (1990).
53. Hsu, F. S. et al. Thyrotropin-secreting pituitary adenoma presenting as hypokalemic periodic paralysis. Am. J. Med. Sci. 325, 48-50 (2003).
54. Chen, Y. C., Fang, J. T., Chang, C. T. & Chou, H. H. Thyrotoxic periodic paralysis in a patient abusing thyroxine for weight reduction. Ren. Fail. 23, 139-142 (2001).
55. Chou, H. K., Tsao, Y. T. & Lin, S. H. An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents. Am. J. Med. Sci. 337, 71-73 (2009).
56. Hannon, M. J., Behan, L. A. & Agha, A. Thyrotoxic periodic paralysis due to excessive L thyroxine replacement in a Caucasian man. Ann. Clin. Biochem. 46, 423-425 (2009).
57. Lin, S. H., Davids, M. R. & Halperin, M. L. Hypokalaemia and paralysis. QJM 96, 161-169 (2003). (Pubitemid 36284910)
58. Fisher, J. Thyrotoxic periodic paralysis with ventricular fibrillation. Arch. Intern. Med. 142, 1362-1364 (1982). (Pubitemid 12087793)
59. Loh, K. C., Pinheiro, L. & Ng, K. S. Thyrotoxic periodic paralysis complicated by near-fatal ventricular arrhythmias. Singapore Med. J. 46, 88-89 (2005). (Pubitemid 40203744)
60. Miyashita, Y. et al. Ventricular fibrillation due to severe hypokalemia induced by steroid treatment in a patient with thyrotoxic periodic paralysis. Intern. Med. 45, 11-13 (2006). (Pubitemid 43205154)
61. Wu, C. Z., Wu, Y. K., Lin, J. D. & Kuo, S. W. Thyrotoxic periodic paralysis complicated by acute hypercapnic respiratory failure and ventricular tachycardia. Thyroid 18, 1321-1324 (2008).
62. Kokenge, F. & Heiner, M. Thyrotoxic periodic paralysis: a peculiar case with weekend-related quadriplegia. Endocrinologist 15, 297-299 (2005). (Pubitemid 41395687)
63. Liu, Z., Braverman, L. E. & Malabanan, A. Thyrotoxic periodic paralysis in a Hispanic man after the administration of prednisone. Endocr. Pract. 12, 427-431 (2006). (Pubitemid 44717604)
64. Kane, M. P. & Busch, R. S. Drug-induced thyrotoxic periodic paralysis. Ann. Pharmacother. 40, 778-781 (2006).
65. Wongraoprasert, S., Buranasupkajorn, P., Sridama, V. & Snabboon, T. Thyrotoxic periodic paralysis induced by pulse methylprednisolone. Intern. Med. 46, 1431-1433 (2007).
66. Kemperman, F. A., Hoff, H. C. & de Klerk, G. Hypokalemic periodic paralysis as the sole manifestation of hyperthyroidism [Dutch]. Ned. Tijdschr. Geneeskd. 139, 938-941 (1995).
67. Shizume, K. et al. Studies on electrolyte metabolism in idiopathic and thyrotoxic periodic paralysis. I. Arteriovenous differences of electrolytes during induced paralysis. Metabolism 15, 138-144 (1966).
68. Feely, J. Potassium shift in thyrotoxic periodic paralysis. Postgrad Med. J. 57, 238-239 (1981). (Pubitemid 11096933)
69. Chan, A., Shinde, R., Chow, C. C., Cockram, C. S. & Swaminathan, R. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ 303, 1096-1099 (1991).
70. Gaul, C., Leonhardt, G., Spens, A., Schneyer, U. & Zierz, S. Hypokalemic thyrotoxic periodic paralysis (HTPP). Rare differential diagnosis in case of acute tetraparesis in Europe [German]. Med. Klin. (Munich) 100, 583-586 (2005). (Pubitemid 41372057)
71. Neal, J. M. Thyrotoxic periodic paralysis in a Caucasian man: recognition and diagnosis. Indiana Med. 84, 696-699 (1991).
72. Lin, S. H. & Lin, Y. F. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am. J. Kidney Dis. 37, 620-623 (2001).
73. Norris, K. C., Levine, B. & Ganesan, K. Thyrotoxic periodic paralysis associated with hypokalemia and hypophosphatemia. Am. J. Kidney Dis. 28, 270-273 (1996). (Pubitemid 26286665)
74. Lin, S. H. et al. Early diagnosis of thyrotoxic periodic paralysis: spot urine calcium to phosphate ratio. Crit. Care Med. 34, 2984-2989 (2006).
75. Bernard, P., Rault, A. & Talarmin, F. Hypokalemic periodic paralysis at initiation of Graves' disease treatment. Two observations [French]. Presse Med. 30, 221 (2001).
76. Navarro, V., Fournier, E., Girard, S., Delattre, J. Y. & Eymard, B. Periodic hypokalemic paralysis as the manifestation of Graves' disease: clinical and electrophysiological study [French]. Rev. Neurol. (Paris) 156, 59-61 (2000). (Pubitemid 30084392)
77. Hawkins, B. R., Ma, J. T., Lam, K. S., Wang, C. C. & Yeung, R. T. Association of HLA antigens with thyrotoxic Graves' disease and periodic paralysis in Hong Kong Chinese. Clin. Endocrinol. (Oxf.) 23, 245-252 (1985). (Pubitemid 16218800)
78. Puvanendran, K., Cheah, J. S. & Wong, P. K. Electromyographic (EMG) study in thyrotoxic periodic paralysis. Aust. N. Z. J. Med. 7, 507-510 (1977). (Pubitemid 8238064)
79. Tengan, C. H. et al. Periodic paralysis: anatomo-pathological study of skeletal muscles in 14 patients [Portuguese]. Arq. Neuropsiquiatr. 52, 32-40 (1994).
80. Cheah, J. S., Tock, E. P. & Kan, S. P. The light and electron microscopic changes in the skeletal muscles during paralysis in thyrotoxic periodic paralysis. Am. J. Med. Sci. 269, 365-374 (1975).
81. Sokolina, N. A., Il'ina, N. A. & Korolev, V. V. Change in the ultrastructure of the muscles in thyrotoxic periodic paralysis [Russian]. Arkh. Patol. 38, 27-33 (1976).
82. Tassone, H., Moulin, A. & Henderson, S. O. The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature. J. Emerg. Med. 26, 157-161 (2004). (Pubitemid 38234806)
83. Shayne, P. & Hart, A. Thyrotoxic periodic paralysis terminated with intravenous propranolol. Ann. Emerg. Med. 24, 736-740 (1994). (Pubitemid 24302845)
84. Huang, T. Y. & Lin, S. H. Thyrotoxic hypokalemic periodic paralysis reversed by propranolol without rebound hyperkalemia. Ann. Emerg. Med. 37, 415-416 (2001).
85. Birkhahn, R. H., Gaeta, T. J. & Melniker, L. Thyrotoxic periodic paralysis and intravenous propranolol in the emergency setting. J. Emerg. Med. 18, 199-202 (2000). (Pubitemid 30105820)
86. Yeung, R. T. & Tse, T. F. Thyrotoxic periodic paralysis. Effect of propranolol. Am. J. Med. 57, 584-590 (1974).
87. Caciotti, A., Morrone, A., Domenici, R., Donati, M. A. & Zammarchi, E. Severe prognosis in a large family with hypokalemic periodic paralysis. Muscle Nerve 27, 165-169 (2003). (Pubitemid 36169327)
88. Okihiro, M. M. & Nordyke, R. A. Hypokalemic periodic paralysis. Experimental precipitation with sodium liothyronine. JAMA 198, 949-951 (1966).
89. Gallagher, E. J. Is thyrotoxic periodic paralysis a " channelopathy"? J. Emerg. Med. 17, 123-127 (1999).
90. Chan, A., Shinde, R., Chow, C. C., Cockram, C. S. & Swaminathan, R. Hyperinsulinaemia and Na+, K(+)-ATPase activity in thyrotoxic periodic paralysis. Clin. Endocrinol. (Oxf.) 41, 213-216 (1994). (Pubitemid 24239926)
91. Shishiba, Y., Shimizu, T., Saito, T. & Shizume, K. Elevated immunoreactive insulin concentration during spontaneous attacks in thyrotoxic periodic paralysis. Metabolism 21, 285-290 (1972).
92. Soonthornpun, S., Setasuban, W. & Thamprasit, A. Insulin resistance in subjects with a history of thyrotoxic periodic paralysis (TPP). Clin. Endocrinol. (Oxf.) 70, 794-797 (2009).
93. Hamada, N. et al. Transient glucose intolerance during attacks of thyrotoxic periodic paralysis. Horm. Metab. Res. 17, 301-305 (1985). (Pubitemid 15046264)
94. Holloszy, J. O. & Hansen, P. A. Regulation of glucose transport into skeletal muscle. Rev. Physiol. Biochem. Pharmacol. 128, 99-19v(1996).
95. Clausen, T. Hormonal and pharmacological modification of plasma potassium homeostasis. Fundam. Clin. Pharmacol. 24, 595-605 (2010).
96. Antes, L. M., Kujubu, D. A. & Fernandez, P. C. Hypokalemia and the pathology of ion transport molecules. Semin. Nephrol. 18, 31-45 (1998). (Pubitemid 28063127)
97. Abbott, G. W. et al. MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell 104, 217-231 (2001). (Pubitemid 32174838)
98. Tricarico, D., Servidei, S., Tonali, P., Jurkat-Rott, K. & Camerino, D. C. Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis. J. Clin. Invest. 103, 675-682 (1999). (Pubitemid 29122420)
99. Cannon, S. C. An expanding view for the molecular basis of familial periodic paralysis. Neuromuscul. Disord. 12, 533-543 (2002). (Pubitemid 34756825)
100. Ruff, R. L. Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K+ current. Neurology 53, 1556-1563 (1999). (Pubitemid 29491953)
101. Puwanant, A. & Ruff, R. L. INa and IKir are reduced in Type 1 hypokalemic and thyrotoxic periodic paralysis. Muscle Nerve 42, 315-327 (2010).
102. Lin, H. et al. Thyroid hormones suppress ε-PKC signalling, down-regulate connexin 43 and increase lethal arrhythmia susceptibility in non-diabetic and diabetic rat hearts. J. Physiol. Pharmacol. 59, 271-285 (2008). (Pubitemid 351955752)
103. Muscella, A. et al. PKC ε dependent cytosol to membrane translocation of pendrin in rat thyroid PC Clvcells. J. Cell Physiol. 217, 103-112 (2008).
104. Watanabe, H. et al. Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium. Biochem. Biophys. Res. Commun. 308, 439-444 (2003). (Pubitemid 36945510)
105. Casas, F. et al. Overexpression of the mitochondrial Tvreceptor p43 induces a shift in skeletal muscle fiber types. PLoS ONE 3, e2501 (2008).
106. Miyabara, E. H. et al. Thyroid hormone receptor β selective agonist GC 24 spares skeletal muscle type I to II fiber shift. Cell Tissue Res. 321, 233-241 (2005). (Pubitemid 41127030)
107. Biering, H., Bauditz, J., Pirlich, M., Lochs, H. & Gerl, H. Manifestation of thyrotoxic periodic paralysis in two patients with adrenal adenomas and hyperandrogenaemia. Horm. Res. 59, 301-304 (2003). (Pubitemid 36649388)
108. Azzarolo, A. M. et al. Androgen support of lacrimal gland function. Endocrine 6, 39-45 (1997). (Pubitemid 27211795)
109. Song, M. et al. Remodeling of Kv4.vpotassium channel gene expression under the control of sex hormones. J. Biol. Chem. 276, 31883-31890 (2001).
110. Ryan, D. P. & Ptácek, L. J. in The Molecular and Genetic Basis of Neurologic and Psychiatric Disease (eds Rosenberg, R. N., DiMauro, S., Paulson, H. L., Ptácek, L. J. & Nestler, E. J.) 550-568 (Lippincott Williams & Wilkins, Philadelphia, 2007).
111. Ng, W. Y., Lui, K. F., Thai, A. C. & Cheah, J. S. Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis. Thyroid 14, 187-190 (2004). (Pubitemid 38452190)
112. Wang, W. et al. Mutation screening in Chinese hypokalemic periodic paralysis patients. Mol. Genet. Metab. 87, 359-363 (2006).
113. Sternberg, D., Tabti, N., Fournier, E., Hainque, B. & Fontaine, B. Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis. Neurology 61, 857-859 (2003). (Pubitemid 37174493)
114. Lehmann-Horn, F. Disease-causing mutations or functional polymorphisms? Acta Myol. 23, 85-89 (2004).
115. Tang, N. L. et al. The α1S subunit of the L type calcium channel is not a predisposition gene for thyrotoxic periodic paralysis. Clin. Endocrinol. (Oxf.) 66, 229-234 (2007). (Pubitemid 46096143)
116. Plaster, N. M. et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105, 511-519 (2001). (Pubitemid 32520856)
117. Logothetis, D. E., Petrou, V. I., Adney, S. K. & Mahajan, R. Channelopathies linked to plasma membrane phosphoinositides. Pflugers Arch. 460, 321-341 (2010).
118. Nehring, R. B. et al. Neuronal inwardly rectifying K(+) channels differentially couple to PDZ proteins of the PSD 95/SAP90 family. J. Neurosci. 20, 156-162 (2000). (Pubitemid 30220502)
119. Leonoudakis, D. et al. Protein trafficking and anchoring complexes revealed by proteomic analysis of inward rectifier potassium channel (Kir2.x)-associated proteins. J. Biol. Chem. 279, 22331-22346 (2004). (Pubitemid 38679430)
120. Rolim, A. L. R. et al. Ion channelopathies in endocrinology: recent genetic findings and pathophysiological insights. Arq. Bras. Endocrinol. Metabol. 54, 673-681 (2010).